Presentations

  1. October 10-11 2019. GUCY2C CAR-T cell Therapy for Metastatic Colorectal Cancer. Adoptive Cell Transfer Congress, London, United Kingdom.

  2. September 2019. GI Cancer Vaccines in the Adjuvant Setting. Expert Forum on Gastrointestinal Malignancies in Dallas, Texas.

  3. March 2019. GCC-Targeted Immunotherapy for Metastatic Colorectal Cancer. University of Wisconsin, Carbone Cancer Center, Cancer Biology Seminar, Madison, Wisconsin.

  4. November 2018. GCC-Targeted Immunotherapy for Metastatic Colorectal Cancer. Lankenau Institute for Medical Research (LIMR) in Wynnewood, Pennsylvania.

  5. September 2018. Translating CAR-T to Gastrointestinal Malignancies. Expert Forum on Gastrointestinal Malignancies in Dallas, Texas.

  6. June 2018. Progress and Opportunities in Cancer Immunotherapy. The 7th International Conference on Plasma Medicine (ICPM-7) in Philadelphia, Pennsylvania.

  7. April 2018. GUCY2C-Targeted CAR-T Cell Therapy for Gastrointestinal Cancers. Cancer & Immunotherapy Symposium 2018, hosted by ACEA Biosciences in Chicago, Illinois.

  8. December 2017. Development of GUCY2C-Targeted CAR-T Cell Therapy for Metastatic Colorectal Cancer. The American Society for Cell Biology (ASCB) / European Molecular Biology Organization (EMBO) 2017 Meeting in Philadelphia, Pennsylvania.

  9. November 2017. GUCY2C as an Immunotherapeutic Target in Gastrointestinal Malignancies. La Salle University Biology Club Seminar Series in Philadelphia, Pennsylvania.

  10. December 2008. Cancer Mucosa Antigens Are Novel Immunological Targets for Tumor Therapy. Presentat at Tumor Immunology: New Perspectives, hosted by the American Association for Cancer Research in Miami, Florida.

  11. May 2008. Cancer Mucosa Antigens as Novel Immunological Targets for Tumor Therapy. Presented at Advances in Cancer Vaccines, hosted by Cambridge Healthtech Institute in Cambridge Massachusetts.